. Purpose: The association between lower-extremity loading and clinically relevant knee symptoms at different time points after anterior cruciate ligament reconstruction (ACLR) is unclear. Vertical ground reaction force (vGRF) from walking was compared between individuals with and without clinically relevant knee symptoms in three cohorts: G12 months post-ACLR, 12-24 months post-ACLR, and 924 months post-ACLR. Methods: One hundred twenty-eight individuals with unilateral ACLR were classified as symptomatic or asymptomatic, based on previously defined cutoff values for the Knee Osteoarthritis and Injury Outcome Score (G12 months post-ACLR [symptomatic n = 28, asymptomatic n = 24]; 12-24 months post-ACLR [symptomatic n = 15, asymptomatic n = 15], and 924 months post-ACLR [symptomatic, n = 13; asymptomatic, n = 33]). Vertical ground reaction force exerted on the ACLR limb was collected during walking gait, and functional analyses of variance were used to evaluate the effects of symptoms and time post-ACLR on vGRF throughout stance phase (> = 0.05). Results: Symptomatic individuals, G12 months post-ACLR, demonstrated less vGRF during both vGRF peaks (i.e., weight acceptance and propulsion) and greater vGRF during midstance, compared to asymptomatic individuals. Vertical ground reaction force characteristics were not different between symptomatic and asymptomatic individuals for most of stance in individuals between 12 and 24 months post-ACLR. Symptomatic individuals who were 924 months post-ACLR, exhibited greater vGRF during both peaks, but lesser vGRF during midstance, compared to asymptomatic individuals. Conclusion: Relative to asymptomatic individuals, symptomatic individuals are more likely to underload the ACLR limb early after ACLR (i.e., G12 months) during both vGRF peaks, but overload the ACLR limb, during both vGRF peaks, at later time points (i.e., 924 months). We propose these differences in lowerextremity loading during walking might have implications for long-term knee health, and should be considered when designing therapeutic interventions for individuals with an ACLR.
F orty percent of individuals continue to report clinically relevant knee symptoms, based on the Knee Injury and Osteoarthritis Outcome survey (KOOS), 2 yr post-anterior cruciate ligament reconstruction (ACLR) (1) . Poor patient reported outcomes might reflect underlying joint tissue changes related to poor long-term knee health. Specifically, lower KOOS scores are associated with magnetic resonance imaging outcomes related to altered femoral cartilage composition 12 months after ACLR (2), suggesting worse patientreported outcomes may be related to the early development of posttraumatic osteoarthritis (PTOA). Furthermore, persistent knee symptoms are associated with chronic abnormal loading of the lower extremity (3, 4) , potentially hastening deleterious changes in joint tissues (5-8). Unfortunately, the association between lower-extremity loading and persistent clinically relevant knee symptoms is unclear.
Evidence from animal models clearly demonstrates that both excessive (9) and insufficient mechanical loading (10, 11) can cause deleterious changes to weight bearing joints. Greater impulsive loading has been demonstrated in the ACLR limb compared to the contralateral limb (12) , as well as a matched limb of uninjured controls (13) in two cohorts of females a mean of approximately 4 and 5 yr post-ACLR, respectively. Conversely, lesser loading of the ACLR limb in the first 6 months after ACLR is associated with deleterious changes in biomarkers of cartilage metabolism at 6 months post-ACLR (14) , worse patient reported outcomes 12 months post-ACLR (3), and a greater likelihood of radiographic PTOA 5 yr post-ACLR (15) . Overall, the available evidence regarding the association between lower-extremity joint loading and knee joint health is contradictory, and additional research is needed to clarify the association between lower-extremity loading and patientreported outcomes at various time points after ACLR (e.g., G12, 12-24, and 924 months). A greater understanding of how movement strategies differ between symptomatic and asymptomatic individuals with ACLR is critical for developing treatments to optimize gait biomechanics post ACLR. Additionally, the influence of time because ACLR on joint loading in individuals with and without clinically relevant symptoms is unknown.
The primary purpose of this cross-sectional study was to compare walking vGRF applied to the ACLR limb, throughout the stance phase, between individuals with and without clinically relevant knee symptoms at multiple time points after ACLR. Comparisons were made between three cross-sectional cohorts separated into clinically relevant time periods: 1) G12 months post-ACLR, 2) between 12 and 24 months post-ACLR, and 3) 924 months post-ACLR. We defined clinically relevant knee symptoms based on previously defined cutoff scores for the KOOS (16) . Vertical ground reaction force is a fundamental measure of lower-extremity loading during gait. Discrete measures related to vGRF during gait (i.e., peak vGRF and the corresponding vGRF load rate) have been linked to knee joint health outcomes, including biochemical markers of joint metabolism (14, 17) , cartilage composition (18) , and patient reported outcomes (3). However, assessing discrete vGRF characteristics provides a limited evaluation of forces acting on the lower-extremity loading during stance. Analysis of the vGRF time series waveform, throughout the stance phase of gait, likely provides a more comprehensive indicator of lower-extremity loading. Therefore, we hypothesized individuals G12 months post-ACLR, with clinically relevant knee symptoms, would demonstrate less vGRF, throughout stance, compared to individuals without clinically relevant knee symptoms. In individuals between 12 and 24 months post-ACLR, and 924 months post-ACLR, we hypothesized that individuals with clinically relevant knee symptoms would demonstrate greater vGRF throughout stance, relative to individuals without clinically relevant knee symptoms.
METHODS
Participants were recruited into a combined crosssectional study (N = 128; Table 1 ) leveraging multiple ongoing studies, including a separate cross-sectional project (n = 36), prospective longitudinal ACL cohort study (n = 36), and randomized controlled trial (n = 56) evaluating the immediate effects of vibration therapy on individuals with an ACLR (NCT02605876). All data in the current study were collected before any intervention and the same protocols, as well as equipment were used to collect gait biomechanics and KOOS data for all participants. For the current study, all participants performed the gait analysis during a single session and were separated into time post-ACLR cohorts based on the number of months post-ACLR at the time of the analysis. All participants provided informed consent approved by the Institutional Review Board at the University of North Carolina at Chapel Hill before participation in any research related procedures. Participants. Individuals between the ages of 18 and 35 yr who sustained a unilateral ACL injury and underwent ACLR were included (Table 1) . Individuals with any of the following were excluded: history of any other lower-extremity orthopedic surgery, ACLR revision surgery, multi-ligament reconstruction at the time of ACLR, physician diagnosed knee osteoarthritis (radiographically diagnosed or diagnosed based on symptoms), balance or neuromuscular disorders, or history of an orthopedic injury in either limb during 6 months before testing (12, 17) . Potential participants were recruited from university health system orthopedic clinics, university club sport teams, university varsity athletics, and the general university community.
Vertical ground reaction force acquisition. Before gait analysis, participants were outfitted with retroreflective markers, including a rigid cluster of three markers over the sacrum used to determine walking speed, as previously described (19) . Marker positions were quantified using a 10-camera 3D motion capture system (120 Hz) and Vicon Nexus v1.4.1 software (Vicon Motion Systems, Santa Rosa, CA, USA). Marker trajectories were lowpass filtered at 10 Hz (4 th order recursive Butterworth), and vGRF data were sampled at 1200 Hz and lowpass filtered at 75 Hz (fourth-order recursive Butterworth). For each of the five acceptable walking trials, vGRF data during the stance phase for the involved limb, defined as the interval between heel strike (vGRF 920 N) and toe off (vGRF G20 N), were extracted and time normalized to 100% of stance phase using 500 data points, as well as normalized to body weight (BW) for each subject; this processing was performed using custom algorithms in MATLAB (version R2017A, MathWorks, Natick, MA, USA).
Participants walked barefoot at a self-selected speed (Table 1 ) over a 40 Â 60 cm force plate (FP406010; Bertec Corporation, Columbus, OH) embedded in a 6-m walkway. Participants were instructed to walk as if they were ''comfortably walking over a sidewalk'' while looking straight ahead and maintaining a constant speed through two sets of timing gates (TF100; Trac Tronix, Lenexa, KS). Participants were allowed as much time as necessary to acclimate to walking in the lab. Once the participants indicated they felt comfortable with the marker setup, they performed five practice trials used to further familiarize the participants with the gait task and determine the self-selected walking speed. During data collection, participants performed five acceptable gait trials, which required participants to (1): place the entire foot on the force plate (2), maintain forward eye contact (not aim for the force plate) (3), walk within 5% of the aforementioned self-selected speed, and FIGURE 1-Vertical ground reaction force differences between symptomatic and asymptomatic individuals in three cohorts, subplots A-C depict mean ensemble waveforms and corresponding 95% confidence intervals, plotted over the stance phase of walking, for mean vGRF, normalized to BW, for symptomatic and asymptomatic individuals with an ACLR in three different cohorts based on time post-ACLR (G12 months-A, 12-24 months-B, and 924 months postoperative-C). Vertical shaded bands in subplots A to C represent percentages in the stance phase where symptomatic and asymptomatic ensemble means differ based on the corresponding functional comparisons in subplots D to F. Subplots D to F show corresponding pairwise comparison functions, and associated 95% confidence intervals (gray bands), indicating the mean differences between the symptomatic and asymptomatic groups for the VGRF (although excluded to increase clarity, the precise mean difference is always exactly between the upper and lower 95% confidence interval). For subplots D to F, the mean differences (vertical axis) represent the symptomatic mean minus the asymptomatic mean at each percentile of the stance phase. Significant between-group differences existed whenever the 95% confidence intervals did not overlap zero.
http://www.acsm-msse.org (4) not visibly alter gait during the trial (i.e., no trip or stutter step) (14, 17, 20) .
Knee injury and osteoarthritis outcomes score (KOOS). We used the five subscales of the KOOS to assess pain (KOOS pain), symptoms (KOOS Symptoms), function in activities of daily living (KOOS ADL), function in activities of sport and recreation (KOOS Sport), and knee-related quality of life (KOOS QOL) (21) . All KOOS subscales demonstrate acceptable reliability (ICCs = 0.75-0.96) and construct validity compared to the Short Form-36 questionnaire in individuals with an ACLR (22) . The KOOS was electronically scored to minimize processing error and each subscale was normalized to 100%, which was considered the best possible score for each subscale of the KOOS, such that higher scores indicated better patient-reported outcomes.
Based on a previous definition (16), participants were dichotomized into those with clinically relevant knee symptoms after ACLR and those with acceptable outcomes at the 12-month follow-up examination. Individuals who reported KOOS QOL e 87.5, and met two or more of the other four subscales cutoff values (KOOS Symptoms e85.7; KOOS Pain e86.1; KOOS ADL e86.8, KOOS Sports e85.0) were considered to demonstrate clinically relevant knee symptoms (16) . We considered individuals who were not categorized as demonstrating clinically significant knee symptoms as asymptomatic. Approximately 43% (n = 1530) and 39% (n = 1506) of the individuals enrolled in the Multicenter Orthopaedic Outcomes Network (MOON) Knee Project cohort demonstrated clinically significant knee symptoms using the same criteria at 2 and 6 yr after ACLR, respectively (1). The present participants (N = 128) were divided into symptomatic and asymptomatic groups, based on (1) KOOS scores, and (2) time (months) post-ACLR (Table 1) .
Statistical analysis. Before our primary analyses, potential differences in discrete demographic variables (Table 1) between the symptomatic and asymptomatic participants for each of the different post-ACLR cohorts were evaluated using independent t tests (> = 0.05; SPSS, Version 19.0; IBM Corp., Somers, NY). Next, 2 Â 2 functional analyses of variance (23) were used to evaluate the effects of group (symptomatic and asymptomatic) and time post-ACLR cohort (G12, 12-24, and 924 months) on the time-normalized vGRF waveform. The functional approach facilitated comparison of vGRF magnitude at each percentile of the stance phase rather than only at certain discrete time points. The vGRF ensemble averages were plotted for the symptomatic and asymptomatic groups in the different post-ACLR cohorts with corresponding 95% confidence intervals. The functional analyses of variance were performed using the functional data analysis package in R statistical computing software (version 3.4.3) to compute mean differences and corresponding 95% confidence intervals between symptomatic and asymptomatic ensemble averages at each percent of stance. The symptomatic and asymptomatic groups were considered different at any percentile of the stance phase where mean differences and corresponding 95% confidence intervals did not cross zero (23) .
RESULTS
Mean age and stance duration were significantly greater in the asymptomatic individuals compared to the symptomatic individuals in the 924-month post-ACLR cohort (Table 1) . No other demographic differences were found between symptomatic and asymptomatic groups in each cohort.
Statistical differences for vGRF existed between the symptomatic and asymptomatic individuals at various times throughout the stance phase for each cohort (G12, 12-24, and 924 months post-ACLR). For the G12-month cohort, vGRF was an average mean difference up to 0.05 BW less for the symptomatic group, between 10% and 22%, and between 68% and 90% of stance, but greater (an average mean difference up to 0.03 BW more) between 32% and 53% of stance (Fig. 1D) . For the 12 to 24 months cohort, differences in vGRF were only found between the symptomatic and asymptomatic groups between 85% and 100% of stance (symptomatic group was greater; Fig. 1E ). vGRF was up to 0.07 BW greater for the symptomatic individuals in the 924 months cohort, between 2% and 5%, 15% and 32%, and 68% and 89% of stance, but up to 0.07 BW less between 39 and 62% of stance (Fig. 1F) .
Differences between symptomatic and asymptomatic individuals varied among the three cohorts (Fig. 2) . Figure 2A illustrates an interaction between group (i.e., symptomatic and asymptomatic individuals) and cohorts (i.e., G12 months and 12-24) during 32% to 58%, and 73% to 99% of stance. Primarily, between-group differences existed for the G12-month cohort, but not for the 12-to 24-month post-ACLR cohort. Similarly, Figure 2B 
34%, 43% to 57%, 68% to 79%, and 93% to 99% of stance. During these percentages of stance, primarily, between-group differences existed for the 924 months post-ACLR cohort but not for the 12 to 24 months post-ACLR cohort.
Differences between cohorts were more substantial for the symptomatic individuals compared to the asymptomatic individuals (Figs. 3-5) . When comparing symptomatic individuals in the G12 months and 12 to 24 months cohorts, the symptomatic individuals in the G12 months cohort exhibited less vGRF (average mean difference as much as 0.06 BW less; between group effect size Cohen_s d = j0.599) between 0% and 26% of stance, and throughout the majority of the final 26% of stance. Additionally, there was an average mean difference as much as 0.04 BW (d = 0.613) greater vGRF between 34% and 65% of stance in symptomatic individuals in the G12 months compared to the symptomatic 12 to 24 months cohort (Fig. 3C) . When comparing symptomatic individuals in the 12 to 24 months and 924 months cohorts, the symptomatic individuals in the 12 to 24 month cohort exhibited an average mean difference as much as 0.05 BW less vGRF (d = j0.642) between 15% and 32%, and 67% and 86% of stance, and as much as 0.05 BW greater vGRF (d = 0.506) between 40% and 57% of stance (Fig. 3D) . The asymptomatic individuals exhibited relatively fewer differences between post-ACLR cohorts (Fig. 4) . vGRF differed only between 5% and 8% (about 0.04 BW; d = j0.348) and between 92% and 97% (about 0.03 BW; d = 0.382) of stance when comparing the G12 months and 12 to 24 months cohorts (Fig. 4C) . Similarly, vGRF for the asymptomatic individuals differed only between 27% and 35% (about 0.02 BW; d = 0.331) and 92% and 98% (about 0.03 BW; d = j0.393) of stance, when comparing the 12 to 24 months and 924 months cohorts (Fig. 4D) . Figures 5A and B illustrate mean vGRF plots for symptomatic and asymptomatic groups for each post-ACLR cohort, and further demonstrate the symptomatic individuals differed relatively more, between the three cohorts, compared with the asymptomatic individuals.
DISCUSSION
Consistent with our hypothesis, we found differences in vGRF between symptomatic and asymptomatic individuals for each post-ACLR cohort, and the direction of these differences varied depending upon time post-ACLR (Fig. 1) . This is the first study to demonstrate this type of interaction, for walking vGRF between symptomatic and asymptomatic individuals, across different time points post-ACLR.
Overall, the data demonstrate a tendency for clinically FIGURE 3-Differences in symptomatic individuals between cohorts. A depicts mean ensemble waveforms and corresponding 95% confidence intervals, plotted over the stance phase of walking, for mean vGRF, normalized to BW, for symptomatic individuals with an ACLR, in the G12 months post-ACLR cohort and 12 to 24 months post-ACLR cohort. B depicts a similar comparison, except for the considered cohorts are: 12-24 months and 924 months post-ACLR. Vertical shaded bands in subplots A and B percentages in the stance phase where ensemble means differ based on the corresponding functional comparisons in subplots C and D. C and D depict corresponding pairwise comparison functions, and associated 95% confidence intervals (gray bands), indicating the mean differences between the two cohorts, for the VGRF. For C and D, significant betweensymptom group differences existed whenever the 95% confidence intervals did not overlap zero (although excluded to increase clarity, the precise mean difference is always exactly between the upper and lower 95% confidence interval). Walking vGRF significantly differed, across a large majority of the stance phase, when comparing G12 months and 12 to 24 months, and 12 to 24 months and 924 months post-ACLR cohorts.
http://www.acsm-msse.org symptomatic ACLR patients, G12 months post-ACLR, to underload the ACLR limb during the weight acceptance and propulsive aspects of stance (i.e., the first and final third of stance), relative to asymptomatic counterparts; conversely, the clinically symptomatic patients who were 924 months post-ACLR overloaded the ACLR limb during the weight acceptance and propulsion periods of stance (Figs. 1A, C , D, and F). These findings support the notion that mechanical loading of the lower extremity is associated with clinically relevant knee symptoms post ACLR, and the association may be influenced by time post-ACLR. Previous literature is equivocal regarding whether excessive or insufficient loading contributes to post-ACLR knee joint health, and the present data suggest that both excessive and insufficient loading might influence post-ACLR knee joint health. Given the link between persistent clinically relevant symptoms for post-ACLR patients and negative changes in joint health (2, 24) , these findings provide insight into FIGURE 4-Differences in asymptomatic individuals between cohorts, A depicts mean ensemble waveforms and corresponding 95% confidence intervals, plotted over the stance phase of walking, for mean vGRF, normalized to BW, for asymptomatic individuals with an ACLR, in the G12 months post-ACLR cohort and 12 to 24 months post-ACLR cohort. B depicts a similar comparison, except the considered cohorts are: 12 to 24 months and 924 months post-ACLR. Vertical shaded bands in subplots A and B percentages in the stance phase where ensemble means differ based on the corresponding functional comparisons in subplots C and D. For C and D, significant between-symptom group differences existed whenever the 95% confidence intervals did not overlap zero (although excluded to increase clarity, the precise mean difference is always exactly between the upper and lower 95% confidence interval). Walking vGRF significantly differed, across a large majority of the stance phase, when comparing G12 months and 12 to 24 months, and 12 to 24 months and 924 months post-ACLR cohorts.
FIGURE 5-Vertical ground reaction force in symptomatic and asymptomatic individuals in all cohorts, mean ensemble plots for vGRF, time normalized to the stance phase of walking and normalized to BW, for the symptomatic (A) and asymptomatic (B) individuals for the months post-ACLR cohorts. Measures of variance were omitted here to enhance clarity, and were comparable between the plotted curves. The symptomatic individuals differed more, between the three cohorts, relative to the asymptomatic individuals.
loading patterns which associate with poorer clinical outcomes in separate cohorts of individuals at different times post-ACLR.
At the beginning of stance, vGRF rapidly increases at its greatest rate to the first vGRF peak. This weight acceptance phase of gait results in substantial load applied to the lower extremity, including the knee. Peak vGRF in the first 6 months post-ACLR associate with multiple aspects of knee joint health including, serum biochemical markers of cartilage metabolism at the same time point (14) , self-reported function at 12 months post ACLR (3), and tibiofemoral compositional changes at 2 yr post-ACLR (18) . Therefore, differences in vGRF between symptomatic and asymptomatic individuals during the beginning of stance may be critical for understanding chronic changes in knee joint health. For each of the three cohorts, differences existed between symptomatic and asymptomatic subjects during the first third of stance; therefore, symptomatic individuals were experiencing different loads applied to the ACLR limb shortly after ground contact, relative to asymptomatic counterparts. It may also be important to consider vGRF throughout the final two thirds of stance phase of gait in addition to the weight acceptance portion of stance. The midstance phase of gait has been referred to as the unloading phase because vGRF at this time is less than the weight acceptance and propulsive peaks. Our findings indicated symptomatic individuals who were G12 months post-ACL, demonstrated greater vGRF during midstance, while symptomatic individuals who were 924 months post-ACLR demonstrated decreased vGRF during midstance. Loading of the limb during midstance may be critical for optimizing joint tissue mechanics, and maintaining overall cartilage health; however, further research is necessary to determine how changes in midstance loading impacts knee health. The vGRF waveform characterized by Wasserstein et al. (1) decreased weight acceptance vGRF peak, but (2) greater vGRF during midstance in symptomatic individuals G12 months post-ACLR found in our study is similar to individuals experiencing paininduced kinesiophobia (19) . It is possible pain-related fear of movement may play a role in the altered movement patterns found between those with and without symptoms in the first 12 months after ACLR. Yet, recent work has found kinesiophobia does not associate with peak gait mechanics in the first 50% of stance in individuals with an ACLR (25) , suggesting that fear of pain with movement may not have a strong influence on limb loading during walking in individuals who have returned to unrestricted activity. Abnormal vGRF during any part of stance, including the middle and final third could detrimentally influence knee joint health (26, 27) , and should be quantified in this context, throughout the stance phase, rather than only during impact loading. The present statistical approach (functional analysis of variance) allowed for the detection of differences in vGRF throughout stance, including the middle and final thirds of the stance phase, which have been studied to a lesser magnitude in this context. Thus, we contend the present analytical approach provides a more comprehensive assessment of loading, relative to assessment of vGRF magnitudes only at discrete time points (e.g., peak vGRF).
Excessive (9) and/or insufficient loading (10, 11) can influence deleterious changes to joint tissue health, yet definitive identification of specific biomechanical variables associated with poor clinical outcomes, post-ACLR, lacks. It has long been hypothesized that greater mechanical loading of the knee is the mechanism leading to poor long-term outcomes and early osteoarthritis onset (28) (29) (30) . Although existing evidence supports this hypothesis, related literature is inconsistent. Females with ACLR, with a mean of 4 to 5 yr post-ACLR, demonstrate greater peak vGRF and vGRF load rates in the ACLR limb, relative to the contralateral limb (12) and matched limbs of uninjured controls (13) . Likewise, greater peak vGRF during gait is associated with deleterious changes in cartilage composition 24 months after ACLR (18) . Conversely, lesser vGRF-loading rate and knee abduction moment, 6 months after ACLR, are each associated with greater serum biomarkers of inflammation and degenerative cartilage enzymes (14) . Also, individuals who developed PTOA 5 yr after ACLR demonstrated decreased knee contact force at a 6-month follow-up compared with those who did not develop PTOA (15) . The present results may partially explain these contradictions and support the ideas that abnormal biomechanics, in the ACLR limb, are (1) related to clinical outcomes, and (2) vary over time post-ACLR. It is important to further evaluate mechanisms leading to changes in loading after ACLR. Although not statistically different, symptomatic individuals (1.31 T 0.26) walked faster than asymptomatic counterparts (1.18 T 0.19; see Table 1 ) in the 924-month post-ACLR cohort during gait analysis, which may partially explain greater loading during stance phase (31) and the statistically lesser stance duration in the symptomatic group (see Table 1 ). Slower habitual walking speeds are predictive of incident idiopathic knee osteoarthritis (32) and greater serum concentrations of type-II collagen breakdown (20) and higher T1rho magnetic resonance imaging relaxation times associated with lesser femoral cartilage proteoglycan density (33) in individuals with an ACLR. It is possible greater walking speeds may be an adaptive response by symptomatic individuals to protect underlying joint tissues, as shorter stance phases during faster gait speeds may result in lesser compression of viscoelastic structures such as articular cartilage (34) . The results of the present study imply a progression, from underloading to overloading, for clinically symptomatic patients post ACLR (Figs. 1 and 5 ); yet longitudinal research is needed to confirm these hypotheses, as well as determine if underloading or overloading results in long-term deleterious changes in joint health.
Our cross-sectional study design is unable to determine causality between altered walking vGRF and clinically related knee symptoms. It is possible symptomatic individuals underload the ACLR limb early after ACLR (Fig. 1A) an attempt to alleviate symptoms. It is also possible that early underloading of the ACLR limb is due to inadequate neuromuscular control (35) or impaired proprioception (36) . In a recent study evaluating peak vGRF in the first 50% of the http://www.acsm-msse.org stance phase of gait (3), individuals with more asymmetrical underloading 6 months post-ACLR (lesser peak vGRF in the ACLR limb compared to the uninjured limb) demonstrated worse KOOS scores 12 months post-ACLR, suggesting early altered loading may influence worse patient reported outcomes at later follow ups. We can further hypothesize, overtime, insufficient loading of the ACLR limb may signal deleterious changes in joint tissues (11) , and manifest in increased knee symptoms. Similarly, mechanisms related to greater vGRF peaks at later time points (e.g., 924 months) in symptomatic individuals are unclear, yet we hypothesize that these increases in vGRF may also be caused by neuromuscular or proprioceptive impairments influencing the inability to control and attenuate energy directed toward the lower extremity during gait (37, 38) . It remains unknown why symptomatic individuals G12 months underload the ACLR limb, whereas symptomatic individuals 924 months overload the ACLR limb compared with asymptomatic counterparts; yet, mechanisms related to early underloading may be associated to later overloading. It is possible that symptoms may lead to aberrant loading early after ACLR, whereas aberrant loading may further perpetuate the development of symptoms at later time points (e.g., 924 months post-ACLR). Future longitudinal studies are needed to determine the precise causes of altered lower-extremity biomechanics, at multiple time points after ACLR, in symptomatic and asymptomatic individuals.
The current study is novel and important, yet some additional limitations exist and should be highlighted to inform future research. First, we did not evaluate the influence of concomitant injury (i.e. meniscal injury) or graft type on differences in vGRF between symptomatic and asymptomatic individuals. Future, larger-scale studies should determine the effects of concomitant injury and graft selection in this context. Similarly, participants in our study sustained a unilateral ACL injury, and we are unable to generalize our results to individuals with multiple ACL injuries. We have presented data describing barefoot gait at a self-selected walking speed and future research should evaluate shod walking, as well as other movement patterns, including movements involving greater vGRF (e.g., running, jumping and landing). Future research should also evaluate activities of daily living in the real world (i.e., outside of the lab). Although vGRF is a fundamental measure of lower-extremity loading and associated with compositional (18), structural (15) , and selfreported (3) aspects of knee joint health, vGRF cannot specifically describe magnitudes or locations of forces absorbed by specific knee joint structures. Further research is needed to determine if differences in walking vGRF correspond with differences in joint-specific biomechanical parameters (e.g., knee joint kinematics and kinetics), as well as critical discrete biomechanical variables within the waveform analysis (e.g., peak vGRF and vGRF loading rate). The focus of the current study was to evaluate differences in vGRF between symptomatic and asymptomatic individuals with an ACLR; future work evaluating interlimb asymmetries, for symptomatic and asymptomatic individuals, would further elucidate the issues addressed in the present study. Finally, although the present separation of participants into symptomatic and asymptomatic individuals was novel, we do not know whether the symptomatic individuals in the current study will develop PTOA or chronic disability.
In conclusion, vGRF differs between clinically symptomatic and asymptomatic individuals, post-ACLR, and these differences vary depending upon time post-ACLR. Within the G12 months post-ACLR cohort, symptomatic individuals demonstrated less vGRF during approximately the first and last thirds of stance, but greater vGRF during the midstance phase of gait, relative to asymptomatic individuals. Within the 12 to 24 months post-ACLR cohort, vGRF was relatively similar between the symptomatic and asymptomatic individuals. For the 924 months post-ACLR cohort, symptomatic individuals applied greater vGRF during the first and second vGRF peaks, but less vGRF during midstance, relative to the asymptomatic individuals. These differences may influence chronic knee joint health for post-ACLR patients and should be considered when designing and evaluating interventions aimed at manipulating load applied to the post-ACLR knee.
